Washington DC Methadone Treatment

Subscribe Here To Have Your Clinic Featured in this space

Following payment completion, please email us the clinic information that will be displayed here.

methadone8c



Washington DC provides fairly extensive resources for opiate-addicted individuals. In addition to a substantial number of area methadone clinics, there are many private Washington DC doctors able to provide prescriptions for Suboxone. Both methadone and suboxone are very effective in reducing the discomfort associated with opioid withdrawal. We have listed below a number of links on the Methadone.US website providing additional information to readers on how methadone is effectively utilized in a treatment program, opioid dependence facts, an addiction counseling overview, and recent job openings in methadone clinics across the country.


Washington, D.C. Methadone Clinics
Partners in Drug Abuse Rehabilitation
and Counseling (PIDARC)
2112 F Street NW, Suite 102
Washington, DC 20037
(202) 296-4455×3202
UPO Comprehensive Treatment Center 33 N Street NE, 2nd Floor
Washington, DC 20002
(202) 682-6599×6588
Good Hope Institute 1320 Good Hope Road SE
Washington, DC 20020
(202) 610-1886
Veterans Affairs Medical Center
Substance Abuse Rehabilitation Program
50 Irving Street NW 3-C North, Unit 116-A
Washington, DC 20422
(202) 745-8336×7168
Psychiatric Institute of Washington 4228 Wisconsin Avenue NW
Washington, DC 20016
(202) 885-5600
Alexandria Community Services Board
Substance Abuse Services
2355-A Mill Road
Alexandria, VA 22314
(703) 746-3600
Prince Georges County Health Dept
Addictions/Northern Region
3003 Hospital Drive, Ground Floor
Cheverly, MD 20785
(301) 583-5920
Fairfax Methadone Treatment Center
(FMTC)
7008 Little River Turnpike, Suite G
Annandale, VA 22003
(703) 333-3113
Inova Comprehensive Addiction
Treatment Services (CATS)
3300 Gallows Road
Falls Church, VA 22042
(703) 776-7777
Montgomery County Dept Health/Human
Services/Outpatient Addiction Services
751 Twinbrook Parkway, 2nd Floor
Rockville, MD 20851
(240) 777-1680

 

Washington, D.C. Buprenorphine Treatment
Dennis Scurry, Jr., M.D. 6323 Georgia Avenue, NW
Unit 208
Washington, DC 20011
(202) 291-0124
Alen Salerian, M.D. 5255 Wisconsin Avenue
Suite 104
Washington, DC 20015
(202) 244-9000
Ted Alan Ramsey, M.D. 4545 42nd Street, NW
Suite 204
Washington, DC 20016
(240) 997-1824
David H. Fram, M.D. 4545 42nd Street, NW
Washington, DC 20016
(202) 686-1870
John F. Dombrowski, M.D. 3301 New Mexico Avenue, NW
Unit 346
Washington, DC 20016
(202) 362-4787
Okay Harold Odocha, M.D. 1140 Varnum Street, NE
Suite #102
Washington, DC 20017
(202) 526-7091
Alex J. Hemphill, Jr., M.D. 1912 Irving Street, NE
Washington, DC 20018
(202) 526-4573
Andrew Christopher Robie, M.D. 1328 W Street SE
Washington, DC 20020
(202) 610-7160
Seth McGregor Garber, M.D. Unity Healthcare Southwest Health Center
850 Delaware Ave SW
Washington, DC 20024
(202) 548-4520
Tyler G. Jones, M.D. Saint Elizabeths Hospital
1100 Alabama Avenue SE
Washington, DC 20032
(202) 645-8783
Gavin Elliot Rose, M.D. 2700 Martin Luther King Avenue, SE
Washington, DC 20032
(202) 645-4933
Srirangam Shreeram, M.D. St. Elizabeths Hospital/ Barton Hall
2nd Floor 2700 M L King Avenue SE
Washington, DC 20032
(202) 645-8778
Beverly Ann Reader, M.D. 908 New Hampshire Avenue NW
Suite 603
Washington, DC 20037
(703) 362-0707
UPO Comprehensive Treatment Center 33 N Street NE
2nd Floor
Washington, DC 20002
(202) 682-6599
Oasis 910 Bladensburg Road NE
Washington, DC 20002
(202) 396-9480
DOH/Addiction Prevention and Recovery
Admin/Womens Services Center
1905 E Street SE
DC General Health Campus Building 13
Washington, DC 20003
(202) 698-3773
Kolmac Clinic 1411 K Street NW
Suite 703
Washington, DC 20005
(202) 638-1992
Andromeda Transcultural Health
Decatur Center
1400 Decatur Street NW
Washington, DC 20011
(202) 291-4707
Psychiatric Institute of Washington
Youth Detoxification
4228 Wisconsin Avenue NW
Washington, DC 20016
(202) 885-5600
Howard University Hospital
Drug Abuse Institute
2041 Georgia Avenue NW
Suite 6B-20
Washington, DC 20060
(202) 865-6611
Walter Reed Army Medical Center
Army Substance Abuse Program
MCWR-DCA-CCC
6900 16th Street NW/Building 6 2nd Fl
Washington, DC 20307
(202) 782-3969
Veterans Affairs Medical Center
Substance Abuse Rehabilitation Program
50 Irving Street NW 3-C North
Unit 116-A
Washington, DC 20422
(202) 745-8336×7168

How Bad Is Opioid Withdrawal

There is an informative video by Sarah Wakeman on the physical and psychological perils of severe opioid withdrawal. Sarah is a Medical Director at Mass General Brigham. They are an integrated health care system that conduct medical research, teaching, and patient care.

In the video, Sarah explains how opioid withdrawal can become so severe with diarrhea and vomiting that individuals can die from extensive dehydration. As physicial dependency progresses, the brain becomes increasingly imbalanced and unable to function without the presence of opioids.

When opioid withdrawal commences (usually 8-12 hours after last use), it becomes increasingly unbearable as the body is flushed with stress hormones. The withdrawal discomfort builds in intensity over days, and can last up to a week or more. For many, this withdrawal process feels akin to a severe case of the flu, but then potentially reaches levels of sickness even far beyond that.

In the video, Sarah goes on to discuss the benefits of methadone and buprenorphine in reducing severe withdrawal symptoms and in helping patients to ultimately not die from overdose. She also illuminates on how rational decision-making is so extremely difficult when struggling against the intense pain of opioid withdrawal.

Please check this video out, and share it with anyone you believe can benefit from its message.

Posted in Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Opiate Withdrawal, Opioid Treatment, Pain Management, Prescription Drugs, Suboxone | Tagged | Comments Off on How Bad Is Opioid Withdrawal

Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone

 
Opioid addiction (now commonly referred to as opioid use disorder) is a treatable illness that can be effectively managed with the help of beneficial medications like buprenorphine or methadone. These medications excel in eliminating the troublesome withdrawal sickness that often results from prolonged use of opiates. Medication, by itself, aids in alleviating withdrawal symptoms. But counseling and therapy are necessary to help patients develop an understanding of their illness and the skills necessary to successfully cope with potential relapse risks.